Castelein Caley - Insider Non-Derivative Transactions at Tourmaline Bio, Inc. (TRML) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Oct 27, 2023, Castelein Caley's relationship to Tourmaline Bio, Inc. (TRML) is Director, and currently has 516,519 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other TRML insiders.
Data Source: SEC.
Castelein Caley - Insider Non-Derivative Transactions of TRML Common Stock
Castelein Caley - Insider Non-Derivative Transactions at TRML
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Oct 28, 2023 | P -- (Common Stock) | 15800 | 14.55 | 516519 |
| Oct 26, 2023 | P -- (Common Stock) | 4200 | 12.07 | 500719 |
| Oct 20, 2023 | Acquisition -- (Common Stock) | 458039 | 0 | 458039 |
| Oct 20, 2023 | Acquisition -- (Common Stock) | 496519 | 0 | 496519 |